Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Telemedicine | 32 | 2024 | 3104 | 3.350 |
Why?
|
Alcoholism | 9 | 2024 | 1993 | 2.700 |
Why?
|
Mental Health Services | 21 | 2023 | 1732 | 2.160 |
Why?
|
Substance-Related Disorders | 26 | 2024 | 4453 | 2.030 |
Why?
|
Mental Disorders | 26 | 2024 | 6879 | 1.980 |
Why?
|
Opioid-Related Disorders | 15 | 2024 | 2188 | 1.780 |
Why?
|
Bipolar Disorder | 21 | 2023 | 5124 | 1.540 |
Why?
|
Buprenorphine | 8 | 2024 | 661 | 1.470 |
Why?
|
Deductibles and Coinsurance | 12 | 2024 | 316 | 1.390 |
Why?
|
Health Benefit Plans, Employee | 6 | 2023 | 332 | 1.050 |
Why?
|
Hospitals, Psychiatric | 3 | 2021 | 318 | 1.040 |
Why?
|
Medicare | 20 | 2024 | 6881 | 0.980 |
Why?
|
Health Expenditures | 15 | 2024 | 2391 | 0.960 |
Why?
|
Fee-for-Service Plans | 4 | 2022 | 714 | 0.900 |
Why?
|
Opiate Substitution Treatment | 6 | 2024 | 446 | 0.890 |
Why?
|
Psychiatry | 9 | 2022 | 1714 | 0.880 |
Why?
|
Antimanic Agents | 5 | 2014 | 524 | 0.860 |
Why?
|
Patient Isolation | 2 | 2020 | 100 | 0.850 |
Why?
|
Restraint, Physical | 2 | 2020 | 185 | 0.790 |
Why?
|
Alcohol-Related Disorders | 2 | 2024 | 243 | 0.780 |
Why?
|
Ambulatory Care | 9 | 2024 | 2780 | 0.740 |
Why?
|
Pandemics | 18 | 2024 | 8753 | 0.720 |
Why?
|
Psychiatric Department, Hospital | 1 | 2020 | 125 | 0.690 |
Why?
|
Medicaid | 14 | 2021 | 2843 | 0.680 |
Why?
|
United States | 66 | 2024 | 73121 | 0.680 |
Why?
|
Lipoproteins, HDL | 1 | 2024 | 682 | 0.660 |
Why?
|
Mental Health | 10 | 2024 | 3271 | 0.650 |
Why?
|
Antipsychotic Agents | 10 | 2023 | 3077 | 0.630 |
Why?
|
Healthcare Disparities | 5 | 2020 | 3412 | 0.630 |
Why?
|
Quality of Health Care | 8 | 2012 | 4340 | 0.610 |
Why?
|
Insurance Coverage | 10 | 2022 | 1946 | 0.560 |
Why?
|
Office Visits | 1 | 2020 | 596 | 0.530 |
Why?
|
Antidepressive Agents | 9 | 2017 | 2913 | 0.520 |
Why?
|
Central Nervous System Stimulants | 1 | 2024 | 1180 | 0.490 |
Why?
|
Rural Population | 6 | 2021 | 2317 | 0.470 |
Why?
|
Schizophrenia | 8 | 2020 | 6986 | 0.460 |
Why?
|
Electroconvulsive Therapy | 1 | 2019 | 502 | 0.450 |
Why?
|
Medical Informatics | 1 | 2021 | 737 | 0.450 |
Why?
|
Confidentiality | 1 | 2018 | 606 | 0.440 |
Why?
|
Case Management | 1 | 2015 | 276 | 0.440 |
Why?
|
Medication Adherence | 5 | 2017 | 2190 | 0.440 |
Why?
|
Government Regulation | 1 | 2018 | 525 | 0.440 |
Why?
|
Patient Readmission | 3 | 2020 | 3308 | 0.440 |
Why?
|
Humans | 121 | 2024 | 768451 | 0.440 |
Why?
|
Research Subjects | 1 | 2015 | 249 | 0.440 |
Why?
|
Health Services Accessibility | 7 | 2022 | 5510 | 0.430 |
Why?
|
Diffusion of Innovation | 1 | 2018 | 730 | 0.430 |
Why?
|
Aftercare | 4 | 2023 | 921 | 0.420 |
Why?
|
Adjustment Disorders | 1 | 2013 | 68 | 0.420 |
Why?
|
Adult | 56 | 2024 | 223542 | 0.410 |
Why?
|
Electronic Health Records | 4 | 2021 | 4877 | 0.400 |
Why?
|
Outpatients | 6 | 2024 | 1607 | 0.400 |
Why?
|
Inpatients | 5 | 2022 | 2561 | 0.390 |
Why?
|
Borderline Personality Disorder | 1 | 2019 | 775 | 0.370 |
Why?
|
Electronics | 3 | 2022 | 318 | 0.370 |
Why?
|
Adolescent | 28 | 2024 | 89168 | 0.370 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2022 | 10358 | 0.360 |
Why?
|
Managed Care Programs | 5 | 2013 | 941 | 0.360 |
Why?
|
Substance Abuse Treatment Centers | 3 | 2020 | 167 | 0.360 |
Why?
|
Psychotherapy | 6 | 2020 | 1656 | 0.350 |
Why?
|
Commitment of Mentally Ill | 1 | 2010 | 94 | 0.350 |
Why?
|
Health Services | 1 | 2015 | 756 | 0.350 |
Why?
|
Mentally Ill Persons | 1 | 2010 | 126 | 0.340 |
Why?
|
Middle Aged | 46 | 2024 | 223418 | 0.340 |
Why?
|
Young Adult | 25 | 2024 | 60045 | 0.330 |
Why?
|
Insurance, Health | 9 | 2024 | 2513 | 0.320 |
Why?
|
Nurse Practitioners | 2 | 2022 | 271 | 0.320 |
Why?
|
Male | 57 | 2024 | 364781 | 0.320 |
Why?
|
Patient Compliance | 2 | 2010 | 2696 | 0.310 |
Why?
|
Insurance Claim Review | 4 | 2020 | 745 | 0.310 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2024 | 3742 | 0.310 |
Why?
|
Female | 60 | 2024 | 396943 | 0.300 |
Why?
|
Depressive Disorder | 3 | 2017 | 3738 | 0.290 |
Why?
|
Child Custody | 1 | 2007 | 20 | 0.290 |
Why?
|
Alcohol Deterrents | 2 | 2024 | 49 | 0.290 |
Why?
|
Patient Acceptance of Health Care | 5 | 2023 | 3237 | 0.280 |
Why?
|
Longitudinal Studies | 7 | 2024 | 14766 | 0.280 |
Why?
|
Patient Selection | 3 | 2015 | 4266 | 0.280 |
Why?
|
Diagnosis, Dual (Psychiatry) | 2 | 2018 | 303 | 0.270 |
Why?
|
Patient Participation | 1 | 2015 | 1450 | 0.270 |
Why?
|
Community Mental Health Services | 2 | 2011 | 389 | 0.250 |
Why?
|
Medicare Part D | 3 | 2016 | 358 | 0.250 |
Why?
|
Drug Prescriptions | 4 | 2024 | 1677 | 0.250 |
Why?
|
Methadone | 2 | 2024 | 322 | 0.230 |
Why?
|
Biochemical Phenomena | 1 | 2024 | 59 | 0.230 |
Why?
|
Depressive Disorder, Major | 3 | 2013 | 4816 | 0.220 |
Why?
|
Organizational Innovation | 1 | 2007 | 540 | 0.220 |
Why?
|
Naltrexone | 2 | 2023 | 319 | 0.220 |
Why?
|
Disulfiram | 1 | 2022 | 63 | 0.200 |
Why?
|
Aged | 27 | 2024 | 171520 | 0.200 |
Why?
|
Advanced Practice Nursing | 1 | 2022 | 18 | 0.200 |
Why?
|
Attitude | 1 | 2007 | 773 | 0.200 |
Why?
|
Models, Psychological | 2 | 2020 | 835 | 0.200 |
Why?
|
Assisted Living Facilities | 1 | 2022 | 27 | 0.200 |
Why?
|
Cohort Studies | 14 | 2023 | 41797 | 0.190 |
Why?
|
Ownership | 2 | 2021 | 343 | 0.190 |
Why?
|
Patients | 1 | 2007 | 909 | 0.180 |
Why?
|
Comorbidity | 5 | 2024 | 10601 | 0.180 |
Why?
|
Alcohol Drinking | 2 | 2024 | 4052 | 0.170 |
Why?
|
Health Services Research | 2 | 2014 | 1815 | 0.170 |
Why?
|
Analgesics, Opioid | 5 | 2023 | 3837 | 0.170 |
Why?
|
Patient Admission | 1 | 2007 | 1370 | 0.170 |
Why?
|
Quality Indicators, Health Care | 4 | 2011 | 1813 | 0.160 |
Why?
|
Narcotic Antagonists | 2 | 2022 | 590 | 0.160 |
Why?
|
Drug Utilization | 5 | 2020 | 1192 | 0.160 |
Why?
|
Health Care Costs | 5 | 2020 | 3265 | 0.150 |
Why?
|
Insurance Benefits | 2 | 2013 | 187 | 0.150 |
Why?
|
Residential Treatment | 1 | 2019 | 112 | 0.150 |
Why?
|
Meta-Analysis as Topic | 1 | 2023 | 1364 | 0.150 |
Why?
|
Treatment Outcome | 6 | 2019 | 65409 | 0.140 |
Why?
|
Rural Health Services | 1 | 2021 | 392 | 0.140 |
Why?
|
Hospitals | 2 | 2021 | 3906 | 0.140 |
Why?
|
Health Planning | 3 | 2023 | 233 | 0.140 |
Why?
|
Florida | 4 | 2013 | 430 | 0.140 |
Why?
|
Legislation, Medical | 2 | 2022 | 98 | 0.140 |
Why?
|
Physicians, Primary Care | 1 | 2023 | 621 | 0.130 |
Why?
|
Mass Screening | 3 | 2019 | 5455 | 0.130 |
Why?
|
Affective Symptoms | 1 | 2019 | 418 | 0.130 |
Why?
|
Depression, Postpartum | 2 | 2011 | 355 | 0.130 |
Why?
|
Cost Sharing | 3 | 2020 | 409 | 0.130 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2019 | 389 | 0.130 |
Why?
|
Health Care Rationing | 2 | 2013 | 436 | 0.130 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2018 | 348 | 0.130 |
Why?
|
Health Care Surveys | 3 | 2021 | 2437 | 0.120 |
Why?
|
Retrospective Studies | 11 | 2024 | 81834 | 0.120 |
Why?
|
Patient Preference | 2 | 2023 | 948 | 0.120 |
Why?
|
Depression | 4 | 2023 | 8235 | 0.120 |
Why?
|
Medically Uninsured | 1 | 2020 | 841 | 0.120 |
Why?
|
Violence | 1 | 2000 | 937 | 0.110 |
Why?
|
Federal Government | 2 | 2006 | 266 | 0.110 |
Why?
|
Child | 11 | 2024 | 80863 | 0.110 |
Why?
|
Logistic Models | 4 | 2015 | 13324 | 0.110 |
Why?
|
Hospitals, General | 1 | 2018 | 807 | 0.110 |
Why?
|
Cross-Sectional Studies | 6 | 2024 | 26351 | 0.110 |
Why?
|
Decision Making | 3 | 2023 | 3961 | 0.110 |
Why?
|
Risperidone | 1 | 2016 | 383 | 0.110 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2015 | 6035 | 0.110 |
Why?
|
Reproducibility of Results | 3 | 2023 | 20231 | 0.100 |
Why?
|
Risk Adjustment | 1 | 2016 | 603 | 0.100 |
Why?
|
Health Services Needs and Demand | 2 | 2013 | 1408 | 0.100 |
Why?
|
Urban Population | 1 | 2020 | 2047 | 0.100 |
Why?
|
Insurance Claim Reporting | 2 | 2018 | 166 | 0.100 |
Why?
|
Interviews as Topic | 3 | 2023 | 2733 | 0.100 |
Why?
|
Interpersonal Relations | 1 | 2019 | 1439 | 0.100 |
Why?
|
Information Dissemination | 2 | 2018 | 1138 | 0.100 |
Why?
|
Area Under Curve | 1 | 2015 | 1640 | 0.090 |
Why?
|
Hospitalization | 6 | 2022 | 10845 | 0.090 |
Why?
|
Anxiety Disorders | 1 | 2022 | 2754 | 0.090 |
Why?
|
Patient Discharge | 2 | 2023 | 3471 | 0.090 |
Why?
|
Drugs, Generic | 1 | 2016 | 454 | 0.090 |
Why?
|
Maryland | 2 | 2021 | 277 | 0.090 |
Why?
|
Patient-Centered Care | 1 | 2020 | 1439 | 0.090 |
Why?
|
Aged, 80 and over | 7 | 2022 | 59680 | 0.090 |
Why?
|
Needs Assessment | 1 | 2016 | 1146 | 0.090 |
Why?
|
Multicenter Studies as Topic | 1 | 2015 | 1727 | 0.080 |
Why?
|
Medicare Part C | 3 | 2022 | 332 | 0.080 |
Why?
|
United States Food and Drug Administration | 3 | 2013 | 1669 | 0.080 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2010 | 140 | 0.080 |
Why?
|
Psychotherapy, Group | 2 | 2021 | 414 | 0.080 |
Why?
|
Primary Health Care | 2 | 2022 | 4737 | 0.080 |
Why?
|
Patient Satisfaction | 1 | 2021 | 3484 | 0.080 |
Why?
|
Inappropriate Prescribing | 1 | 2011 | 212 | 0.080 |
Why?
|
Psychometrics | 2 | 2015 | 3072 | 0.080 |
Why?
|
Amines | 1 | 2010 | 280 | 0.080 |
Why?
|
Off-Label Use | 1 | 2010 | 186 | 0.080 |
Why?
|
New York | 1 | 2010 | 882 | 0.070 |
Why?
|
Patents as Topic | 1 | 2009 | 113 | 0.070 |
Why?
|
Conflict of Interest | 1 | 2013 | 556 | 0.070 |
Why?
|
Self Report | 1 | 2019 | 3771 | 0.070 |
Why?
|
Massachusetts | 1 | 2020 | 8908 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15965 | 0.070 |
Why?
|
Anti-Anxiety Agents | 1 | 2010 | 405 | 0.070 |
Why?
|
Probability | 2 | 2011 | 2483 | 0.070 |
Why?
|
Social Security | 1 | 2007 | 101 | 0.070 |
Why?
|
National Health Insurance, United States | 1 | 2007 | 100 | 0.070 |
Why?
|
Benzodiazepines | 1 | 2013 | 1139 | 0.070 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 7134 | 0.070 |
Why?
|
Motivation | 1 | 2016 | 2034 | 0.070 |
Why?
|
Remission Induction | 1 | 2012 | 2408 | 0.070 |
Why?
|
Qualitative Research | 3 | 2023 | 3115 | 0.060 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2009 | 490 | 0.060 |
Why?
|
Students | 1 | 2015 | 1751 | 0.060 |
Why?
|
Disease Management | 1 | 2016 | 2533 | 0.060 |
Why?
|
Continuity of Patient Care | 2 | 2011 | 1076 | 0.060 |
Why?
|
Reference Standards | 1 | 2009 | 1015 | 0.060 |
Why?
|
Practice Guidelines as Topic | 4 | 2008 | 7451 | 0.060 |
Why?
|
Quality Improvement | 1 | 2020 | 3858 | 0.060 |
Why?
|
Organizational Policy | 2 | 2013 | 434 | 0.060 |
Why?
|
Long-Term Care | 1 | 2009 | 633 | 0.060 |
Why?
|
Child, Preschool | 3 | 2024 | 42623 | 0.060 |
Why?
|
Data Collection | 2 | 2006 | 3329 | 0.060 |
Why?
|
Psychotic Disorders | 1 | 2019 | 3278 | 0.060 |
Why?
|
Time Factors | 2 | 2020 | 40271 | 0.060 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2010 | 1140 | 0.050 |
Why?
|
Guideline Adherence | 3 | 2014 | 2239 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2015 | 14728 | 0.050 |
Why?
|
Cost of Illness | 1 | 2013 | 1960 | 0.050 |
Why?
|
Family Therapy | 1 | 2004 | 214 | 0.050 |
Why?
|
Computer Simulation | 1 | 2016 | 6278 | 0.050 |
Why?
|
Medical Savings Accounts | 1 | 2022 | 34 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12096 | 0.050 |
Why?
|
Cost Control | 1 | 2004 | 627 | 0.050 |
Why?
|
Child Health Services | 1 | 2007 | 645 | 0.050 |
Why?
|
Drug Costs | 1 | 2009 | 1196 | 0.050 |
Why?
|
New Jersey | 2 | 2011 | 295 | 0.040 |
Why?
|
Emergency Service, Hospital | 4 | 2023 | 7956 | 0.040 |
Why?
|
Databases, Factual | 1 | 2016 | 8081 | 0.040 |
Why?
|
Quality Assurance, Health Care | 1 | 2011 | 2179 | 0.040 |
Why?
|
United States Substance Abuse and Mental Health Services Administration | 1 | 2020 | 21 | 0.040 |
Why?
|
Health Care Reform | 2 | 2012 | 1256 | 0.040 |
Why?
|
Homes for the Aged | 1 | 2022 | 273 | 0.040 |
Why?
|
Diagnosis-Related Groups | 1 | 2000 | 448 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15460 | 0.040 |
Why?
|
Specialization | 1 | 2024 | 782 | 0.040 |
Why?
|
Poverty | 1 | 2011 | 2719 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2011 | 8559 | 0.040 |
Why?
|
Health Policy | 1 | 2011 | 2699 | 0.040 |
Why?
|
United States Department of Veterans Affairs | 1 | 2023 | 937 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2024 | 15638 | 0.040 |
Why?
|
Family Health | 1 | 2022 | 1256 | 0.040 |
Why?
|
Costs and Cost Analysis | 1 | 2023 | 1670 | 0.040 |
Why?
|
Confidence Intervals | 2 | 2013 | 2932 | 0.040 |
Why?
|
Models, Statistical | 1 | 2012 | 5103 | 0.040 |
Why?
|
Choice Behavior | 1 | 2023 | 846 | 0.040 |
Why?
|
Forecasting | 1 | 2006 | 2950 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10784 | 0.030 |
Why?
|
Minority Groups | 1 | 2024 | 1215 | 0.030 |
Why?
|
Psychotropic Drugs | 1 | 2022 | 888 | 0.030 |
Why?
|
Private Sector | 1 | 2018 | 395 | 0.030 |
Why?
|
Health Facilities | 1 | 2020 | 576 | 0.030 |
Why?
|
Perception | 1 | 2021 | 1207 | 0.030 |
Why?
|
Prognosis | 1 | 2015 | 30028 | 0.030 |
Why?
|
Chronic Disease | 2 | 2022 | 9382 | 0.030 |
Why?
|
Nursing Homes | 1 | 2022 | 1084 | 0.030 |
Why?
|
Risk Assessment | 1 | 2015 | 24311 | 0.030 |
Why?
|
Mood Disorders | 1 | 2020 | 1128 | 0.030 |
Why?
|
Emergency Services, Psychiatric | 1 | 2013 | 64 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2015 | 1007 | 0.030 |
Why?
|
Internship and Residency | 1 | 2013 | 5952 | 0.030 |
Why?
|
Anxiety | 1 | 2007 | 4655 | 0.020 |
Why?
|
Prospective Studies | 1 | 2015 | 54914 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2000 | 2705 | 0.020 |
Why?
|
Treatment Failure | 1 | 2016 | 2656 | 0.020 |
Why?
|
Utilization Review | 1 | 2011 | 384 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2011 | 39430 | 0.020 |
Why?
|
Marketing of Health Services | 1 | 2010 | 151 | 0.020 |
Why?
|
State Health Plans | 1 | 2011 | 220 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5308 | 0.020 |
Why?
|
Observation | 1 | 2010 | 311 | 0.020 |
Why?
|
Drug Compounding | 1 | 2009 | 243 | 0.020 |
Why?
|
Drug Utilization Review | 1 | 2009 | 248 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2013 | 773 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2000 | 2518 | 0.020 |
Why?
|
Models, Organizational | 1 | 2011 | 546 | 0.020 |
Why?
|
Length of Stay | 1 | 2021 | 6521 | 0.020 |
Why?
|
Economic Competition | 1 | 2009 | 223 | 0.020 |
Why?
|
Pain | 1 | 2022 | 5096 | 0.020 |
Why?
|
Cognition | 1 | 2024 | 7066 | 0.020 |
Why?
|
Drug Industry | 1 | 2013 | 793 | 0.020 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2016 | 1189 | 0.020 |
Why?
|
Preventive Health Services | 1 | 2011 | 568 | 0.020 |
Why?
|
Suicidal Ideation | 1 | 2016 | 1466 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2020 | 3922 | 0.020 |
Why?
|
Linear Models | 1 | 2013 | 5880 | 0.010 |
Why?
|
Regression Analysis | 1 | 2011 | 6353 | 0.010 |
Why?
|
Patient Dropouts | 1 | 2003 | 411 | 0.010 |
Why?
|
Social Adjustment | 1 | 2003 | 636 | 0.010 |
Why?
|
Odds Ratio | 1 | 2011 | 9687 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 3708 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2013 | 5887 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2013 | 26395 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2003 | 2665 | 0.010 |
Why?
|
Infant | 1 | 2013 | 36497 | 0.010 |
Why?
|
Risk Factors | 1 | 2016 | 74915 | 0.000 |
Why?
|